Understanding barriers to utilization of 17-hydroxyprogesterone caproate and other interventions to prevent preterm birth in Fresno County, California
Objective Preterm birth is one of the leading causes of neonatal morbidity and mortality. A history of prior spontaneous preterm birth is a known risk factor for recurrent preterm birth. While 17-alpha-hydroxyprogesterone caproate (17P) has been found in some studies to reduce recurrent pre...
Main Authors: | Subhashini Ladella, Amber Shaver, Tania Pacheco-Werner, Cynthia Cortez, Mallory Novack, Andrea Wiemann, Miriam Kuppermann |
---|---|
Format: | Article |
Language: | English |
Published: |
Perinatal Medicine Foundation
2021-08-01
|
Series: | Perinatal Journal |
Online Access: | https://perinataljournal.com/Archive/Article/20210292011 |
Similar Items
-
Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
Published: (2021-07-01) -
Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth
by: Vidaeff AC, et al.
Published: (2013-07-01) -
Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth
by: Travanty MN, et al.
Published: (2018-07-01) -
Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy
by: Kim A. Boggess, et al.
Published: (2018-04-01) -
Effect of 17 α-Hydroxyprogesterone Caproate on the Prevention of Preterm Labor: A Randomized Controlled Trial Study
by: Hamed Jafarpour, et al.
Published: (2020-07-01)